Table 6.
Endothelin concentrations (ng/dL) after interventions.
| Interventions |
|||||
|---|---|---|---|---|---|
| Control | WW | WW + TYR | P value for WW + Tyr |
||
| vs Control | vs WW | ||||
| All participants | 2.15 ± 0.90 | 2.33 ± 1.07 | 2.03 ± 0.82 | 0.572 | 0.031 |
| Women | 2.38 ± 1.07 | 2.57 ± 1.11 | 2.12 ± 0.81 | 0.479 | 0.108 |
| Men | 2.01 ± 0.80 | 2.16 ± 1.08 | 1.99 ± 0.87 | 0.990 | 0.463 |
| Genotype interaction | |||||
| LA | 1.93 ± 0.69 | 2.25 ± 0.96 | 1.89 ± 0.72 | 0.981 | 0.203 |
| NA | 2.24 ± 0.95 | 2.48 ± 1.32 | 2.13 ± 1.07 | 0.747 | 0.068 |
Endothelin-1 concentrations are expressed as mean ± SD (N = 32). WW, white wine; WW + Tyr, white wine plus tyrosol (Tyr) capsules; LA, low activity group metabolizers; NA, normal activity group metabolizers. ANOVA adjusted by age, sex, smoking, acetylsalicylic acid consumption, and baseline levels. *P < 0.05 versus its baseline; P value, significance for inter-intervention comparisons.